PRISM WORKING TOGETHER TOWARDS SCIENTIFIC ADVANCES Trademark

Trademark Overview

On Monday, July 31, 2017, a trademark application was filed for PRISM WORKING TOGETHER TOWARDS SCIENTIFIC ADVANCES with the United States Patent and Trademark Office. The USPTO has given the PRISM WORKING TOGETHER TOWARDS SCIENTIFIC ADVANCES trademark a serial number of 79221074. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, October 24, 2025. This trademark is owned by Sumitomo Dainippon Pharma Co., Ltd.. The PRISM WORKING TOGETHER TOWARDS SCIENTIFIC ADVANCES trademark is filed in the Insurance & Financial Services category with the following description:

Providing grants for research in the medical and pharmaceutical field
prism working together towards scientific advances

General Information

Serial Number79221074
Word MarkPRISM WORKING TOGETHER TOWARDS SCIENTIFIC ADVANCES
Filing DateMonday, July 31, 2017
Status709 - CANCELLED - SECTION 71
Status DateFriday, October 24, 2025
Registration Number5718466
Registration DateTuesday, April 9, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 22, 2019

Trademark Statements

Description of MarkThe mark consists of the stylized wording "PRISM" with the phrase "WORKING TOGETHER TOWARDS SCIENTIFIC ADVANCES" underneath in gray. In the wording "PRISM", the capital letters "PR" and the capital letters "SM" are in the color gray. The letter "I" is formed by two prisms with two spheres above them, appearing as two people, one in indigo and the other in green. All of the above is surrounded by fourteen triangular-shaped lines radiating from the "I" in the stylized wording "PRISM". Seven of the lines appear above the wording in a semi-circular arch in the colors going clockwise from the left: red, orange, yellow, green, blue, indigo, and violet. The remaining seven lines appear in the same semi-circle arch below the wording in the same repeating colors going clockwise from the right. The color white is not claimed as a feature of the mark and represents background and transparent areas.
Indication of Colors claimedThe colors red, orange, yellow, green, blue, indigo, violet and gray are claimed as a feature of the mark.
Goods and ServicesProviding grants for research in the medical and pharmaceutical field

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, October 24, 2025
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSumitomo Pharma Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressOsaka 541-0045
JP
Party NameSumitomo Dainippon Pharma Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOsaka 541-0045
JP
Party NameSumitomo Dainippon Pharma Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka 541-0045
JP

Trademark Events

Event DateEvent Description
Thursday, November 16, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, November 20, 2017LIMITATION FROM ORIGINAL APPLICATION ENTERED
Saturday, November 25, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 25, 2017ASSIGNED TO EXAMINER
Wednesday, November 29, 2017APPLICATION FILING RECEIPT MAILED
Wednesday, November 29, 2017NON-FINAL ACTION WRITTEN
Thursday, November 30, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, December 13, 2017REFUSAL PROCESSED BY MPU
Wednesday, December 13, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, January 11, 2018REFUSAL PROCESSED BY IB
Thursday, March 29, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 29, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 29, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 30, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 20, 2018SUSPENSION LETTER WRITTEN
Friday, April 20, 2018LETTER OF SUSPENSION E-MAILED
Friday, April 20, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, June 14, 2018NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, November 7, 2018ASSIGNED TO LIE
Wednesday, November 14, 2018SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, December 13, 2018EXAMINERS AMENDMENT -WRITTEN
Thursday, December 13, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, December 13, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 13, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, December 13, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 2, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 9, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 9, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, January 22, 2019PUBLISHED FOR OPPOSITION
Tuesday, January 22, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, January 25, 2019NOTIFICATION PROCESSED BY IB
Tuesday, April 9, 2019REGISTERED-PRINCIPAL REGISTER
Friday, July 5, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 9, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, August 3, 2019GENERIC MADRID TRANSACTION CREATED
Saturday, August 3, 2019GENERIC MADRID TRANSACTION SENT TO IB
Friday, October 4, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, September 23, 2022CHANGE OF NAME/ADDRESS REC'D FROM IB
Sunday, December 11, 2022CORRECTION TRANSACTION RECEIVED FROM IB
Monday, January 23, 2023CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Tuesday, April 9, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, October 24, 2025CANCELLED SECTION 71

Related Keywords

scientific advances towards together working prism pharmaceutical field medical research grants providing